✦ LIBER ✦

Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial

✍ Scribed by Bines, J.; Dienstmann, R.; Obadia, R. M.; Branco, L. G. P.; Quintella, D. C.; Castro, T. M.; Camacho, P. G.; Soares, F. A.; Costa, M. E. F.

Book ID: 121732770
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 170 KB
Volume: 25
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

373 Phase II trial of letrozole (a novel

373 Phase II trial of letrozole (a novel oral nonsteroidal aromatase inhibitor) in postmenopausal patients with advanced or recurrent breast cancer

✍ T. Tominaga; Y. Ohashi; R. Abe; M. Yoshida; H. Koyama; Y. Nomura; A.S. Bhatnagar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A Phase III trial comparing anastrozole

A Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma

✍ Aman U. Buzdar; Stephen E. Jones; Charles L. Vogel; Janet Wolter; Paul Plourde; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

The trial was randomized, double blind for anastrozole, open label for for the Arimidex Study Group megestrol acetate, parallel group, and multicenter. Patients were randomly assigned to receive anastrozole, 1 mg (n Å 128); anastrozole, 10 mg (n Å 130); or

3. A randomized trial of the new specifi

3. A randomized trial of the new specific aromatase inhibitor ‘Arimidex’ (anastrozole) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer (ABC)

✍ W. Jonat; A. Howell; C.P. Blomqvist; W. Eiermann; G. Winblad; C.J. Tyrrell; L. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 435 KB

104. Randomized phase III study of the n

104. Randomized phase III study of the new selective aromatase inhibitor arimidex (A) (ZD1033) versus megestrol acetate (MA) in the treatment of postmenopausal women with advanced breast cancer

✍ A.U. Buzdar; P.V. Plourde; S.E. Jones; C.L. Voge; J.M. Wolters; P.D. Eisenberg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A phase II study of a potent and selecti

A phase II study of a potent and selective aromatase inhibitor, anastrozole (ZD-1033), in Japanese postmenopausal women with advanced/recurrent breast cancer

✍ H. Koyama 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Megestrol acetate plus alpha 2a interfer

Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: Results of a multicentric phase II trial

✍ Domenico Amoroso; Francesco Boccardo; Monica Balestrero; Loredana Miglietta; Ful 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 359 KB